Compare Manchester United PLC (MANU) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manchester United PLC vs Novartis AG — how do they compare? Manchester United PLC trades at $22.23 (market cap $3.80B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 77.7× Manchester United PLC's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| MANU | NVS | |
|---|---|---|
Market Cap | $3.80B | $295.37B |
Sector | Media | Health |
52-Week High | $23.53 | $168.62 |
52-Week Low | $15.10 | $119.31 |
Enterprise Value | $4.74B | $336.69B |
Dividend Yield | 1.26% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
